PMU59 - ARE THERE ANY IMPLICIT GUIDELINES FOR INCLUDING ADVERSE EVENTS IN COST-EFFECTIVENESS MODELS INTENDED FOR FRENCH HEALTH AUTHORITIES? AN ANALYSIS OF EFFICIENCY OPINIONS
Oct 1, 2018, 00:00 AM
10.1016/j.jval.2018.09.1895
https://www.valueinhealthjournal.com/article/S1098-3015(18)35197-0/fulltext
Section Title :
Section Order :
1253
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35197-0&doi=10.1016/j.jval.2018.09.1895